Create account

Coverage dated October 8, 2026

STAT+: Roche goes beyond licensing in deal with Chinese biotech

Headline from STAT

Roche is partnering with Chinese startup Defand Therapeutics to discover new medicines.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. STAT

    STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines (opens STAT)

    Published

    STAT's feed description

    Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.

  2. STAT

    STAT+: Roche goes beyond licensing in deal with Chinese biotech (opens STAT)

    Published

    STAT's feed description

    Roche is partnering with Chinese startup Defand Therapeutics to discover new medicines.

STAT+: Roche goes beyond licensing in deal with Chinese biotech | Since Then